FBLG
FibroBiologics, Inc.
1.10$
-4.2%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| – | – | +930.8% | +145.0% | +39.1% | -41.5% | |
| – | – | +460.9% | +251.0% | +54.4% | -55.4% | |
| – | – | +456.8% | +304.4% | +52.6% | -65.0% | |
| – | – | +456.8% | +304.4% | +52.6% | -65.0% | |
| – | – | – | – | – | – | |
| – | – | +401.7% | +19.8% | +29.7% | -74.7% | |
| – | – | +302.3% | +29.8% | +38.6% | -86.2% | |
| – | – | +344.4% | -93.7% | +2,543.4% | -92.6% | |
| – | – | +225.3% | +90.5% | +86.8% | -65.0% | |
| – | – | – | – | +118.3% | +125.1% | |
| – | – | – | – | – | – | |
| – | 0.0% | +0.0% | +0.0% | +1.2% | +35.8% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.